Healthcare -
Biotechnology - NASDAQ - US
$ 9.61
-17.1 %
$ 482 M
Market Cap
-3.28
P/E
RGNX - CASH FROM OPERATIONS
Cash from Operations RGNX - REGENXBIO Inc.
-173 M
LAST VALUE
8.66%
2 YEAR CAGR
-9.96%
5 YEAR CAGR
-53.40%
10 YEAR CAGR